Search by Title Article Topic - Any -AdvocacyAnnual Scientific MeetingAwardsBoard Certification ReviewCertificationClinical DocumentClinical TrialsCoronavirusEarly CareerFellowshipFuture LeadersHeart Failure Awareness 365Heart Failure GuidelinesHF Research FoundationHFSA CommitteesHFSA Comprehensive Heart Failure ReviewHFSA Learning CenterIn The NewsIndustryJournal of Cardiac FailureLeadershipMembershipMentorshipNursingPartnersPatient ResourcePatient StoryPodcastsPresident's UpdatesPress ReleaseProfessional DevelopmentProvider EducationResearchSocial MediaStatementSubmissionsWomen in Heart Failure Article Type - Any -HFSA NewsIndustry NewsPatient NewsPractice News Nov 22 2021 | Bristol Myers Squibb Announces New PDUFA Date for Mavacamten Industry News In The News Industry Read More Nov 19 2021 | Medicare Coverage of Innovative Technology (MCIT) HFSA News Advocacy Read More Nov 16 2021 | US FDA accepts supplemental New Drug Application and grants Priority Review for Jardiance® for adults with heart failure independent of left ventricular ejection fraction Industry News Industry Read More Nov 14 2021 | HFSA President's Update: November 2021 HFSA News President's Updates Read More Nov 12 2021 | Sex Matters (in Heart Failure) HFSA News Journal of Cardiac Failure Press Release Research Read More Pagination First page « First Previous page ‹ Previous … Page 44 Page 45 Page 46 Page 47 Current page 48 Page 49 Page 50 Page 51 Page 52 … Next page Next › Last page Last »
Nov 22 2021 | Bristol Myers Squibb Announces New PDUFA Date for Mavacamten Industry News In The News Industry Read More
Nov 16 2021 | US FDA accepts supplemental New Drug Application and grants Priority Review for Jardiance® for adults with heart failure independent of left ventricular ejection fraction Industry News Industry Read More
Nov 12 2021 | Sex Matters (in Heart Failure) HFSA News Journal of Cardiac Failure Press Release Research Read More
